Relx Plc $RELX Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its holdings in Relx Plc (NYSE:RELX) by 18.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,007,921 shares of the technology company’s stock after purchasing an additional 153,821 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.06% of Relx worth $48,138,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the stock. PNC Financial Services Group Inc. lifted its stake in Relx by 51.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 76,445 shares of the technology company’s stock valued at $3,651,000 after buying an additional 25,950 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of Relx by 2.8% in the third quarter. HighTower Advisors LLC now owns 109,026 shares of the technology company’s stock worth $5,207,000 after acquiring an additional 2,979 shares during the last quarter. Naviter Wealth LLC lifted its position in shares of Relx by 3.9% in the third quarter. Naviter Wealth LLC now owns 45,235 shares of the technology company’s stock valued at $2,160,000 after acquiring an additional 1,712 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Relx by 13.0% during the third quarter. Assetmark Inc. now owns 93,472 shares of the technology company’s stock valued at $4,464,000 after acquiring an additional 10,727 shares during the last quarter. Finally, Plan A Wealth LLC increased its position in Relx by 13.3% during the 3rd quarter. Plan A Wealth LLC now owns 9,523 shares of the technology company’s stock worth $455,000 after purchasing an additional 1,120 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Trading Up 4.2%

RELX opened at $34.06 on Friday. Relx Plc has a 1 year low of $27.57 and a 1 year high of $56.33. The firm has a 50 day moving average price of $36.89 and a 200 day moving average price of $41.90. The company has a debt-to-equity ratio of 2.38, a current ratio of 0.49 and a quick ratio of 0.44.

Relx (NYSE:RELX) last released its quarterly earnings data on Thursday, February 12th. The technology company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.85 by ($0.42). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $6.70 billion. Analysts forecast that Relx Plc will post 1.68 EPS for the current year.

Relx Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, June 24th. Shareholders of record on Friday, May 8th will be given a $0.6559 dividend. The ex-dividend date of this dividend is Friday, May 8th. This represents a yield of 422.0%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on RELX. Citigroup assumed coverage on shares of Relx in a report on Monday, January 12th. They issued a “neutral” rating on the stock. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research note on Monday, February 2nd. Wall Street Zen raised shares of Relx from a “hold” rating to a “buy” rating in a research note on Monday. Zacks Research raised Relx from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Relx in a research report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Relx presently has a consensus rating of “Buy”.

Relx Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.